Published • loading... • Updated
Allergy Therapeutics AIMs to go private… then list in Hong Kong
Summary by BusinessCloud.co.uk
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Allergy Therapeutics AIMs to go private… then list in Hong Kong
Allergy Therapeutics plc is looking to de-list in London – and then intends to join the public markets in Hong Kong. The West Sussex-based MedTech, led by CEO Manuel Llobet (pictured), has maintained a London listing since 2004 but its board has complained of costs amid a 71% drop in its share price this year. The firm, which develops allergy vaccines and immunotherapy treatments, will need 75% of its shareholder base to vote through a cancellat…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
